News

24/7 Wall St. on MSN20m
These 2 Dividend Giants Are at 52-Week Lows. Time to Buy?
One man's trash may be another man's treasure, but dumpster diving when investing carries risks. You have to wade through a ...
Scholar Rock: Apitegromab Approval And Obesity Shot Make For Rating Upgrade
Scholar Rock Holding Corporation's apitegromab shows promise for SMA treatment, aims for 2025 launch. Click for my updated ...
How a New Weight-Loss Pill Could Transform Health
In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...